Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer
Cited by 15
Related Papers
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer
|The Oncologist|2018|96
The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes
|Experimental & Molecular Medicine|2023|34
Integrating muti-omics data to identify tissue-specific DNA methylation biomarkers for cancer risk
|Nature Communications|2024|24